Mundipharma International Ltd. - Company & Market Research Reports

MundiPharma is an Irish owned company established in 1973. There break through drug was sustained release morphine (MST® Continus® tablets). This product was seen as a major advantage in handling cancer treatment pain. MundiPharma focus on three main areas: analgesic, oncology and respiratory therapy areas. They are constantly innovating new products to help people with debilitating diseases. Mundi Pharma is part of a worldwide network of independent associated pharmaceutical companies.

Global Bronchodilators Market 2017-2021 - Product Thumbnail Image

Global Bronchodilators Market 2017-2021

  • Report
  • 83 Pages
From
Pain Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pain Drug Development Pipeline Review, 2017

  • Report
  • 229 Pages
From
Cancer Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Cancer Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 274 Pages
From
Cancer Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Cancer Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 268 Pages
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • 340 Pages
From
Neuropathic Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2017

  • Drug Pipelines
  • 488 Pages
From
Musculoskeletal Pain Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Musculoskeletal Pain Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 1007 Pages
From
Non Malignant pain Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Non Malignant pain Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 44 Pages
From
Osteoarthritis Pain Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Osteoarthritis Pain Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 416 Pages
From
Neuropathic Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H1 2017

  • Drug Pipelines
  • 485 Pages
From
Joint Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Joint Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 130 Pages
From
Chronic Back Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Back Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 95 Pages
From
Chronic Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 489 Pages
From
Post-Operative Pain Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Post-Operative Pain Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 3034 Pages
From
Back Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Back Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 369 Pages
From
Bladder Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Bladder Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 53 Pages
From
Low Back Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Low Back Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 334 Pages
From
Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 119 Pages
From
Acute Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Acute Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 343 Pages
From
Drug Overview: Flutiform - Product Thumbnail Image

Drug Overview: Flutiform

  • Report
  • 17 Pages
From
Loading Indicator
adroll